title: Anaphylactic reaction to oxaliplatin: a case report.
authors.forename: I
authors.initials: I
authors.lastname: Larzillière
authors.forename: S
authors.initials: S
authors.lastname: Brandissou
authors.forename: P
authors.initials: P
authors.lastname: Breton
authors.forename: A
authors.initials: A
authors.lastname: Lingoungou
authors.forename: D
authors.initials: D
authors.lastname: Gargot
authors.forename: J P
authors.initials: JP
authors.lastname: Ramain
authors.forename: C
authors.initials: C
authors.lastname: Harnois
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000707:Anaphylaxis / Q000139:chemically induced*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D012811:Sigmoid Neoplasms / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil